<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03099070</url>
  </required_header>
  <id_info>
    <org_study_id>2016P001834</org_study_id>
    <nct_id>NCT03099070</nct_id>
  </id_info>
  <brief_title>Acute Stress Response in Migraine Sufferers</brief_title>
  <official_title>Acute Stress Response in Migraine Sufferers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Massachusetts General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Massachusetts General Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will examine the influence of stress and fasting on headache activity.
      Participants will receive both a control and stress session and be randomized to either
      fasting or not fasting for the visits.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Stress and headache are intricately interrelated. Stress is thought to contribute to headache
      disorder onset in predisposed individuals, trigger or worsen individual headache episodes in
      those with headache, and exacerbate the progression of a headache disorder. In exacerbating
      headache disorder progression, stress is believed to be a major factor in headache
      transformation from an episodic to a chronic condition.

      Broadly stated, stress is conceptualized as an imbalance between a demand, whether actual or
      perceived, and resources to handle the demand, resulting in a strain on the system. A
      stressor is any challenge or threat, whether objectively verified or not, to normal
      functioning. The stress response is the body's activation of physiological systems to protect
      and restore functioning.

      This study is 2 x 2 experiment using male and female migraine sufferers. Participants will be
      randomized to a fasting or not fasting condition for the visits. Thus, the experiment is a 2
      (control versus stress) x 2 (fasting versus not). During the approximately 4 weeks of
      participation (ranging from 9 to a maximum of 28 days), a participant also will complete a
      twice-daily diary.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 8, 2017</start_date>
  <completion_date type="Anticipated">May 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">May 31, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>2 x 2 randomized crossover design</intervention_model_description>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Headache/Medication Use</measure>
    <time_frame>Duration of lab visit (6 hours)</time_frame>
    <description>The presence of a headache attack that is &gt;= 4/10 on a 0 to 10 scale or a headache attack that requires the use of abortive/analgesic medication</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time to next headache attack</measure>
    <time_frame>48 hours</time_frame>
    <description>Time-to-event analysis using diary information</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Medication use</measure>
    <time_frame>48 hours</time_frame>
    <description>Frequency of abortive/analgesic medication use</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain Scores</measure>
    <time_frame>6 hours</time_frame>
    <description>Intensity of pain ratings (0 to 10 scale)</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">212</enrollment>
  <condition>Migraine Headache</condition>
  <arm_group>
    <arm_group_label>Control, Not-Fasting</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Participants will experience the control intervention and will not fast prior to the lab visit.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control, Fasting</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will experience the control intervention and will fast prior to the lab visit.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Stress, Not-Fasting</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will experience the stress intervention and will not fast prior to the lab visit.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Stress, Fasting</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will experience the stress intervention and will fast prior to the lab visit.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Stress</intervention_name>
    <description>Trier Social Stress Test</description>
    <arm_group_label>Stress, Not-Fasting</arm_group_label>
    <arm_group_label>Stress, Fasting</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Fasting</intervention_name>
    <description>12-hour fasting prior to study visit</description>
    <arm_group_label>Control, Fasting</arm_group_label>
    <arm_group_label>Stress, Fasting</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Women and men 18-65 years of age

          -  A provisional diagnosis of migraine (with or without aura).

          -  Headache frequency of 2 to 15 attacks/month

        Exclusion Criteria:

          -  Presence of a secondary headache disorder (e.g., brain tumor)

          -  Chronic daily headache (&gt; 15 headache days/month) or medication over-use headache (&gt; 8
             abortive medication doses/month)

          -  Recent change in nature of headache symptoms over last 6 weeks

          -  Not being able to read or speak English at a 6th grade level

          -  Any condition that would preclude the safe experience of a benign laboratory stressor
             including seizure disorder, Axis-I psychotic disorder, unstable cardiac conditions

          -  An active substance dependence issue (e.g., alcohol, marijuana) that interferes with
             data collection and headache activity.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Timothy T Houle, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Massachusetts General Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Timothy T Houle, PhD</last_name>
    <email>thoule1@mgh.harvard.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Massachusetts General Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02114</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Timothy T Houle, PhD</last_name>
      <email>thoule1@mgh.harvard.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 28, 2017</study_first_submitted>
  <study_first_submitted_qc>March 28, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">April 4, 2017</study_first_posted>
  <last_update_submitted>March 28, 2017</last_update_submitted>
  <last_update_submitted_qc>March 28, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 4, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Massachusetts General Hospital</investigator_affiliation>
    <investigator_full_name>Timothy Houle</investigator_full_name>
    <investigator_title>Associate Scientist</investigator_title>
  </responsible_party>
  <keyword>Stress</keyword>
  <keyword>Fasting</keyword>
  <keyword>Migraine</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Migraine Disorders</mesh_term>
    <mesh_term>Headache</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

